Effectiveness of BenZalkonium Chloride Gel as Vaginal Contraceptive: a Multicentric Randomized Controlled Trial
A multicentric clinical trial in three Chinese Maternal and Child Hospitals was conducted to evaluate the efficacy, safety and acceptability of newly-developed vaginal contraceptive gel, the optimized benzalkonium chloride (BZK) gel containing 18mg BZK, with comparison to a currently marketed (in China)contraceptive gel LELEMI® containing 50mg Nonoxynol-9 (N-9).
100 Clinical Results associated with Chang Jiang Bio-pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Chang Jiang Bio-pharmaceutical Co., Ltd.
100 Deals associated with Chang Jiang Bio-pharmaceutical Co., Ltd.
100 Translational Medicine associated with Chang Jiang Bio-pharmaceutical Co., Ltd.